Analysts Viewpoint
Immunome Inc (IMNM) Becoming More Attractive for Investors
Immunome Inc’s recently made public that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Menu
Immunome Inc’s recently made public that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s recent filing unveils that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Immunome Inc revealed its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Immunome Inc’s filing revealed that its Director BIENAIME JEAN JACQUES acquired Company’s shares for reported $46900.0 on Jun 03 ’25.
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or